aspirin has been researched along with Hyperlipidemias in 116 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Hyperlipidemias: Conditions with excess LIPIDS in the blood.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We assessed the possible 'synergy' of statins and aspirin (ASA) in reducing vascular events in patients with coronary heart disease, in a post hoc analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study." | 9.11 | Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study. ( Athyros, VG; Bouloukos, VI; Daskalopoulou, SS; Elisaf, M; Kakafika, AI; Mikhailidis, DP; Papageorgiou, AA; Pehlivanidis, AN; Symeonidis, AN, 2005) |
| "These prospective data indicate that neither levels of lipids nor aspirin treatment modified the lack of overall effect of lipoprotein (a) on the risk of a first myocardial infarction in the Physicians' Health Study." | 9.08 | Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study. ( Ariyo, A; Hennekens, CH; Ridker, PM; Stampfer, MJ, 1998) |
| "Beside its therapeutic role in the thrombotic vascular events, Clopidogrel confers significant protection against ischemic myocardial injury by counteracting the platelet-mediated inflammation and oxidative stress associated with HFD-C consumption in animals." | 7.96 | Clopidogrel Prophylaxis Abates Myocardial Ischemic Injury and Inhibits the Hyperlipidemia-Inflammation Loop in Hypercholestrolemic Mice. ( Korish, AA, 2020) |
| "This study aimed to investigate the effectiveness of monotherapy acetylsalicylic acid (ASA) and warfarin for stroke prevention in low-risk atrial fibrillation (AF) by using a population- -based cohort study in Taiwan." | 7.91 | Monotherapy of acetylsalicylic acid or warfarin for prevention of ischemic stroke in low-risk atrial fibrillation: A Easter Asian population-based study. ( Chen, HC; Liu, CY, 2019) |
| "The relation of plasma levels of prostaglandins to the occurrence of flushing induced by niceritrol was investigated." | 7.67 | Increased compliance of niceritrol treatment by addition of aspirin: relationship between changes in prostaglandins and skin flushing. ( Kameda, K; Kihara, S; Kubo, M; Matsuzawa, Y; Nozaki, S; Tarui, S, 1987) |
| " We assessed the possible 'synergy' of statins and aspirin (ASA) in reducing vascular events in patients with coronary heart disease, in a post hoc analysis of the GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study." | 5.11 | Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study. ( Athyros, VG; Bouloukos, VI; Daskalopoulou, SS; Elisaf, M; Kakafika, AI; Mikhailidis, DP; Papageorgiou, AA; Pehlivanidis, AN; Symeonidis, AN, 2005) |
| "These prospective data indicate that neither levels of lipids nor aspirin treatment modified the lack of overall effect of lipoprotein (a) on the risk of a first myocardial infarction in the Physicians' Health Study." | 5.08 | Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study. ( Ariyo, A; Hennekens, CH; Ridker, PM; Stampfer, MJ, 1998) |
| "It appears from this pilot study that preceding niacin with 325 mg of aspirin will decrease the warmth and flushing associated with niacin." | 5.07 | The effect of aspirin on niacin-induced cutaneous reactions. ( Fowler, SF; Hainer, BL; Price, SO; Whelan, AM, 1992) |
| " Over the 10 to 15 years after clinical diagnosis, tight glycemic control probably reduces the risk for blindness and end-stage renal disease, and aggressive control of hypertension, lipid therapy, and aspirin use reduce cardiovascular events." | 4.82 | Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force. ( Donahue, K; Frame, P; Harris, R; Lohr, KN; Rathore, SS; Woolf, SH, 2003) |
| "Beside its therapeutic role in the thrombotic vascular events, Clopidogrel confers significant protection against ischemic myocardial injury by counteracting the platelet-mediated inflammation and oxidative stress associated with HFD-C consumption in animals." | 3.96 | Clopidogrel Prophylaxis Abates Myocardial Ischemic Injury and Inhibits the Hyperlipidemia-Inflammation Loop in Hypercholestrolemic Mice. ( Korish, AA, 2020) |
| "This study aimed to investigate the effectiveness of monotherapy acetylsalicylic acid (ASA) and warfarin for stroke prevention in low-risk atrial fibrillation (AF) by using a population- -based cohort study in Taiwan." | 3.91 | Monotherapy of acetylsalicylic acid or warfarin for prevention of ischemic stroke in low-risk atrial fibrillation: A Easter Asian population-based study. ( Chen, HC; Liu, CY, 2019) |
| " This adherence was concerned particularly with co-medication in patients diagnosed with hypertension, aspirin prescription in elderly patients and the achievement of target lipid levels following the prescription of statins." | 3.79 | Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study. ( Hintersteiner, J; Johnson, J; Kamyar, MR; Kautzky, A; Kautzky-Willer, A; Lemmens-Gruber, R; Saukel, J; Stich, K, 2013) |
| "The proper use of statins and aspirin decrease the risk of coronary heart disease (CHD) among patients with diabetes (DM) and hyperlipidemia." | 3.78 | Utilization of statins and aspirin among patients with diabetes and hyperlipidemia: Taiwan, 1998-2006. ( Chen, YJ; Hwu, CM; Li, CY; Lin, YC; Peng, WC; Yang, CC, 2012) |
| " There are serious deficits in the management of hypertension, hypercholesterolemia and the use of aspirin." | 3.75 | ["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice]. ( Benke, I; Hanefeld, M; Köhler, C; Ott, P; Stelzer, J, 2009) |
| "The relation of plasma levels of prostaglandins to the occurrence of flushing induced by niceritrol was investigated." | 3.67 | Increased compliance of niceritrol treatment by addition of aspirin: relationship between changes in prostaglandins and skin flushing. ( Kameda, K; Kihara, S; Kubo, M; Matsuzawa, Y; Nozaki, S; Tarui, S, 1987) |
| "Although pharmacologic treatment for hyperlipidemia had the greatest favorable impact on the ratio over time, our data also show that maintaining an ideal weight and exercise have beneficial effects." | 2.71 | Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men. ( Buring, JE; Gaziano, JM; Levenson, JW; Scranton, R; Sesso, HD; Stampfer, MJ, 2004) |
| "Ciprofibrate did not inhibit thromboxane B 2 synthesis in platelets." | 2.70 | Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects. ( Cibulová, L; Dzúrik, R; Gajdos, M; Huttová, D; Krivosíková, Z; Mongiellová, V; Spustová, V, 2001) |
| "Eptifibatide was not associated with an increase in intracranial hemorrhage, and no significant effect on nonhemorrhagic stroke was observed." | 2.69 | Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators. ( Alberts, MJ; Berdan, LG; Califf, RM; Deckers, J; Graffagnino, C; Granger, CB; Harrington, RA; Laskowitz, DT; Lincoff, AM; MacAulay, CM; Mahaffey, KW; Miller, JM; Simoons, ML; Sloan, MA; Topol, EJ, 1999) |
| " Further dosage adjustments are made in accordance with a set protocol." | 2.67 | The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results. ( Hansson, L; Zanchetti, A, 1994) |
| "Avoiding hypoglycemia is most important for elderly patients with long history of diabetes and atherosclerosis." | 2.49 | [Cardiovascular event in elderly patients with diabetes mellitus]. ( Nomura, K, 2013) |
| "However, unlike stroke, treatment of hyperlipidemia with statin class drugs or treatment of blood clotting abnormalities with acetylsalicylic acid do not appear to have an effect on VaD incidence or progression." | 2.48 | Pharmacological prevention and treatment of vascular dementia: approaches and perspectives. ( Baskys, A; Cheng, JX, 2012) |
| "The myriad deleterious effects of hyperlipidemia that promote a prothrombotic and antifibrinolytic vascular milieu serve to elucidate the importance of lipid reduction as an additional secondary prevention measure." | 2.38 | Atherothrombotic insights into secondary prevention after acute myocardial infarction. ( Loscalzo, J; Rabbani, LE, 1993) |
| "Aspirin was prescribed in 99." | 1.56 | Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey. ( Akboğa, M; Aktaş, I; Aladağ, N; Arın, CB; Asoğlu, R; Deveci, OS; Doğan, A; Dural, M; Erol, MK; Güneş, Y; Ince, O; Kayıkçıoğlu, M; Kılıçkap, M; Kurt, IH; Örnek, E; Özkan, E; Şen, T; Sinan, ÜY; Somuncu, MU; Tüner, H; Yenerçağ, M; Zeybey, U, 2020) |
| "Hyperlipidemia, with an increasing of prevalence, has become one of the common metabolic diseases in companion animal clinic." | 1.48 | Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia. ( Jiao, ZH; Kong, XJ; Li, JY; Li, SH; Liu, XW; Ma, N; Qin, Z; Yang, YJ, 2018) |
| "The anti-hyperlipidemia effect of aspirin eugenol ester has been confirmed in hyperlipidemic rat induced by high fat diet (HFD)." | 1.46 | Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats. ( Dong, P; Jiao, Z; Kong, X; Li, J; Li, S; Liu, X; Ma, N; Qin, Z; Yang, Y, 2017) |
| " AEE at the dosage of 54 mg/kg significantly decreased levels of TG, TCH and LDL (p < 0." | 1.43 | Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet. ( Karam, I; Kong, XJ; Li, JY; Liu, XW; Ma, N; Yang, YJ; Zhao, XL, 2016) |
| "Compared with the model group, the results showed that AEE at 54 mg/kg dosage could significantly decrease the hyperlipidemia indexes including triglyceride (TG), low density lipoprotein (LDL) and total cholesterol (TCH) (p < 0." | 1.42 | Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia. ( Karam, I; Kong, XJ; Li, JY; Li, SH; Liu, XW; Ma, N; Yang, YJ, 2015) |
| "270 patients (93 with deep vein thrombosis (DVT) or pulmonary embolism (PE), and 177 with non-haemorrhagic stroke (cerebrovascular accident (CVA)) admitted between January 2006 and December 2010 with a discharge diagnosis of either DVT, PE or CVA, who had LAC and antiphospholipid antibodies measured within 6 months from their index admission." | 1.38 | High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study. ( Broder, A; Putterman, C; Tobin, JN, 2012) |
| " The objectives of the present study were to develop a population pharmacokinetic-pharmacodynamic (PK-PD) model for simvastatin and to evaluate its usefulness in predicting the dose-response relationship of simvastatin in patients with hyperlipidaemia." | 1.37 | A population pharmacokinetic-pharmacodynamic model for simvastatin that predicts low-density lipoprotein-cholesterol reduction in patients with primary hyperlipidaemia. ( Ahn, BJ; Chae, HS; Choi, J; Doh, K; Han, S; Jun, YK; Kim, J; Lee, YW; Yim, DS, 2011) |
| "The criteria for dyslipidemia were as follows: total cholesterol > or = 200 mg/dL or LDL-cholesterol > 100 mg/dL, or both, in patients using or not lipid-lowering drugs, and the use of lipid-lowering drugs, even when the total cholesterol or LDL-cholesterol levels were < 200 mg/dL and 100 mg/dL, respectively, or both." | 1.32 | Variability among cardiologists in the management of patients under secondary prevention of ischemic heart disease. ( Alboim, C; Campos, C; Mello, RB; Polanczyk, CA; Rosito, GA; Stein, R, 2004) |
| "Dyslipidemia is associated with macular exudates and vision loss." | 1.32 | Preventing diabetic retinopathy through control of systemic factors. ( Fong, D; Jain, A; Sarraf, D, 2003) |
| "Aspirin was used regularly by 37% of those with CVD and by 13% of those with risk factors only Adjusted odds of regular aspirin use were significantly greater for individuals with CVD than for those with one CVD risk factor (odds ratio [OR] = 4." | 1.31 | Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. ( Fagot-Campagna, A; Narayan, KM; Rolka, DB, 2001) |
| "015), and chronic intake of nitrates (P<0." | 1.30 | Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease. ( Beckmann, R; Binder, BR; Geppert, A; Graf, S; Hornykewycz, S; Huber, K; Schuster, E, 1998) |
| "The value of treatment of hyperlipidemia in reducing the incidence of a first stroke remains to be demonstrated." | 1.28 | Ischemic stroke. How to keep the first one from happening. ( Bundlie, SR, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (12.93) | 18.7374 |
| 1990's | 17 (14.66) | 18.2507 |
| 2000's | 45 (38.79) | 29.6817 |
| 2010's | 34 (29.31) | 24.3611 |
| 2020's | 5 (4.31) | 2.80 |
| Authors | Studies |
|---|---|
| Luo, Y | 1 |
| Zhu, Y | 1 |
| Chen, J | 1 |
| Gao, X | 1 |
| Yang, W | 1 |
| Zou, X | 1 |
| Zhou, X | 1 |
| Ji, L | 1 |
| Giorda, CB | 1 |
| Korish, AA | 1 |
| Erol, MK | 1 |
| Kayıkçıoğlu, M | 1 |
| Kılıçkap, M | 1 |
| Arın, CB | 1 |
| Kurt, IH | 1 |
| Aktaş, I | 1 |
| Güneş, Y | 1 |
| Özkan, E | 1 |
| Şen, T | 1 |
| Ince, O | 1 |
| Örnek, E | 1 |
| Asoğlu, R | 1 |
| Aladağ, N | 1 |
| Zeybey, U | 1 |
| Sinan, ÜY | 1 |
| Dural, M | 1 |
| Tüner, H | 1 |
| Doğan, A | 1 |
| Yenerçağ, M | 1 |
| Akboğa, M | 1 |
| Deveci, OS | 1 |
| Somuncu, MU | 1 |
| Nenna, A | 1 |
| Nappi, F | 1 |
| Lusini, M | 1 |
| Satriano, UM | 1 |
| Schilirò, D | 1 |
| Spadaccio, C | 1 |
| Chello, M | 1 |
| Hatakeyama, Y | 1 |
| Horino, T | 1 |
| Matsumoto, T | 1 |
| Terada, Y | 1 |
| Okuhara, Y | 1 |
| Skolnik, N | 1 |
| Jaffa, FM | 1 |
| Kalyani, RR | 1 |
| Johnson, E | 1 |
| Shubrook, JH | 1 |
| Ma, N | 5 |
| Karam, I | 3 |
| Liu, XW | 4 |
| Kong, XJ | 4 |
| Qin, Z | 3 |
| Li, SH | 3 |
| Jiao, ZH | 2 |
| Dong, PC | 1 |
| Yang, YJ | 4 |
| Li, JY | 4 |
| Liu, X | 2 |
| Kong, X | 1 |
| Li, S | 3 |
| Jiao, Z | 1 |
| Dong, P | 1 |
| Yang, Y | 1 |
| Li, J | 1 |
| Soehnlein, O | 1 |
| Liu, CY | 1 |
| Chen, HC | 1 |
| Bundrick, JB | 1 |
| Litin, SC | 1 |
| Andrews, GP | 1 |
| Almajaan, A | 1 |
| Yu, T | 1 |
| Martini, L | 1 |
| Healy, A | 1 |
| Jones, DS | 1 |
| Kautzky-Willer, A | 1 |
| Stich, K | 1 |
| Hintersteiner, J | 1 |
| Kautzky, A | 1 |
| Kamyar, MR | 1 |
| Saukel, J | 1 |
| Johnson, J | 1 |
| Lemmens-Gruber, R | 1 |
| Wenger, NK | 1 |
| Lackland, DT | 1 |
| Roccella, EJ | 1 |
| Deutsch, AF | 1 |
| Fornage, M | 1 |
| George, MG | 1 |
| Howard, G | 1 |
| Kissela, BM | 1 |
| Kittner, SJ | 1 |
| Lichtman, JH | 1 |
| Lisabeth, LD | 1 |
| Schwamm, LH | 2 |
| Smith, EE | 1 |
| Towfighi, A | 1 |
| Chapin, J | 1 |
| Carlson, K | 1 |
| Christos, PJ | 1 |
| DeSancho, MT | 1 |
| Yao, CS | 1 |
| Yan, SG | 1 |
| Gao, LS | 1 |
| Sun, ZR | 1 |
| Liu, F | 1 |
| Jiang, B | 1 |
| Wang, HB | 1 |
| Wu, QZ | 1 |
| Nomura, K | 1 |
| Lin, HL | 1 |
| Yen, HW | 1 |
| Hsieh, SL | 1 |
| An, LM | 1 |
| Shen, KP | 1 |
| McGrogan, D | 1 |
| Mark, D | 1 |
| Lee, B | 1 |
| O'Donnell, ME | 1 |
| Patel, A | 1 |
| Cass, A | 1 |
| Peiris, D | 1 |
| Usherwood, T | 1 |
| Brown, A | 1 |
| Jan, S | 1 |
| Neal, B | 1 |
| Hillis, GS | 1 |
| Rafter, N | 1 |
| Tonkin, A | 1 |
| Webster, R | 1 |
| Billot, L | 1 |
| Bompoint, S | 1 |
| Burch, C | 1 |
| Burke, H | 1 |
| Hayman, N | 1 |
| Molanus, B | 1 |
| Reid, CM | 1 |
| Shiel, L | 1 |
| Togni, S | 1 |
| Rodgers, A | 1 |
| Łabuz-Roszak, B | 1 |
| Pierzchała, K | 1 |
| Tyrpień, K | 1 |
| Silber, T | 1 |
| Ziemann, U | 1 |
| Ernemann, U | 1 |
| Bischof, F | 1 |
| Siasos, G | 1 |
| Oikonomou, E | 1 |
| Zaromitidou, M | 1 |
| Kioufis, S | 1 |
| Kokkou, E | 1 |
| Mourouzis, K | 1 |
| Vlasis, K | 1 |
| Vavuranakis, M | 1 |
| Stone, PH | 1 |
| Papavassiliou, AG | 1 |
| Tousoulis, D | 1 |
| Feng, A | 1 |
| Chuang, E | 1 |
| Wu, SH | 1 |
| Wang, JC | 1 |
| Chang, SN | 1 |
| Lin, CL | 1 |
| Kao, CH | 1 |
| Zhao, XL | 1 |
| Veeraputhiran, M | 1 |
| Sundermeyer, M | 1 |
| Márk, L | 1 |
| Dani, G | 1 |
| Kiss, Z | 1 |
| Katona, A | 1 |
| Ott, P | 1 |
| Benke, I | 1 |
| Stelzer, J | 1 |
| Köhler, C | 1 |
| Hanefeld, M | 1 |
| Tetik, S | 1 |
| Ak, K | 1 |
| Isbir, S | 1 |
| Eksioglu-Demiralp, E | 1 |
| Arsan, S | 1 |
| Iqbal, O | 1 |
| Yardimci, T | 1 |
| Sanchez-Lopez, J | 1 |
| Muñoz-Cano, R | 1 |
| Bartra, J | 1 |
| Valero, A | 1 |
| Picado, C | 1 |
| Arruda-Olson, AM | 1 |
| Reeder, GS | 1 |
| Bell, MR | 1 |
| Weston, SA | 1 |
| Roger, VL | 1 |
| Triadafilopoulos, G | 1 |
| Lombard, CM | 1 |
| Jobe, BA | 1 |
| Kim, J | 1 |
| Ahn, BJ | 1 |
| Chae, HS | 1 |
| Han, S | 1 |
| Doh, K | 1 |
| Choi, J | 1 |
| Jun, YK | 1 |
| Lee, YW | 1 |
| Yim, DS | 1 |
| Broder, A | 1 |
| Tobin, JN | 1 |
| Putterman, C | 1 |
| Park, JY | 1 |
| Rha, SW | 1 |
| Poddar, KL | 1 |
| Ramasamy, S | 1 |
| Chen, KY | 1 |
| Li, YJ | 1 |
| Choi, BG | 1 |
| Ryu, SK | 1 |
| Choi, JW | 1 |
| Park, SH | 1 |
| Park, S | 1 |
| Elnagar, A | 1 |
| Im, SI | 1 |
| Kim, SW | 1 |
| Na, JO | 1 |
| Choi, CU | 1 |
| Lim, HE | 1 |
| Kim, JW | 1 |
| Kim, EJ | 1 |
| Han, SW | 1 |
| Park, CG | 1 |
| Seo, HS | 1 |
| Oh, DJ | 1 |
| Baskys, A | 1 |
| Cheng, JX | 1 |
| Miao, Z | 1 |
| Jiang, L | 1 |
| Wu, H | 1 |
| Bao, Y | 1 |
| Jiao, L | 1 |
| Wu, J | 1 |
| Hua, Y | 1 |
| Li, Y | 1 |
| Zhu, J | 1 |
| Zhu, F | 1 |
| Ling, F | 1 |
| Lin, YC | 1 |
| Yang, CC | 1 |
| Chen, YJ | 1 |
| Peng, WC | 1 |
| Li, CY | 1 |
| Hwu, CM | 1 |
| Chee, FY | 1 |
| How, CH | 1 |
| Friend, M | 1 |
| Vucenik, I | 1 |
| Miller, M | 1 |
| Levenson, D | 1 |
| Harris, R | 1 |
| Donahue, K | 1 |
| Rathore, SS | 1 |
| Frame, P | 1 |
| Woolf, SH | 1 |
| Lohr, KN | 1 |
| Ersöz, G | 1 |
| Tikiz, H | 1 |
| Yakaryilmaz, A | 1 |
| Tezcan, K | 1 |
| Genç, Y | 1 |
| Korkmaz, S | 1 |
| Brown, AF | 1 |
| Mangione, CM | 1 |
| Saliba, D | 1 |
| Sarkisian, CA | 1 |
| Mohri, M | 1 |
| Talbert, RL | 1 |
| Pieper, JA | 1 |
| Ito, MK | 1 |
| Oganov, RG | 1 |
| Lepakhin, VK | 1 |
| Fitilev, SB | 1 |
| Levin, AM | 1 |
| Titarova, YY | 1 |
| Sytchev, EN | 1 |
| Diener, HC | 1 |
| Arnold, M | 1 |
| Nedeltchev, K | 1 |
| Lyrer, P | 1 |
| Baumgartner, RW | 1 |
| Jain, A | 1 |
| Sarraf, D | 1 |
| Fong, D | 1 |
| Rabelink, TJ | 1 |
| Nakajima, M | 1 |
| Kimura, K | 1 |
| Minematsu, K | 1 |
| Saito, K | 1 |
| Takada, T | 1 |
| Tanaka, M | 1 |
| Scranton, R | 1 |
| Sesso, HD | 1 |
| Stampfer, MJ | 2 |
| Levenson, JW | 1 |
| Buring, JE | 1 |
| Gaziano, JM | 1 |
| Stein, R | 1 |
| Alboim, C | 1 |
| Campos, C | 1 |
| Mello, RB | 1 |
| Rosito, GA | 1 |
| Polanczyk, CA | 1 |
| Fulcher, GR | 1 |
| Amarena, JV | 1 |
| Conner, GW | 1 |
| Gilbert, RE | 1 |
| Hankey, GJ | 1 |
| Malcolm, J | 3 |
| Meggison, H | 2 |
| Sigal, R | 3 |
| Gohlke, H | 1 |
| Shinohara, Y | 2 |
| Athyros, VG | 2 |
| Mikhailidis, DP | 2 |
| Papageorgiou, AA | 1 |
| Bouloukos, VI | 1 |
| Pehlivanidis, AN | 1 |
| Symeonidis, AN | 1 |
| Kakafika, AI | 2 |
| Daskalopoulou, SS | 1 |
| Elisaf, M | 1 |
| Harris, M | 1 |
| Wan, Q | 1 |
| Keough-Ryan, TM | 1 |
| Kiberd, BA | 2 |
| Dipchand, CS | 1 |
| Cox, JL | 1 |
| Rose, CL | 1 |
| Thompson, KJ | 1 |
| Clase, CM | 1 |
| Burgstahler, C | 1 |
| Reimann, A | 1 |
| Beck, T | 1 |
| Kuettner, A | 1 |
| Heuschmid, M | 1 |
| Kopp, AF | 1 |
| Schroeder, S | 1 |
| Markuszewski, L | 1 |
| Rosiak, M | 1 |
| Golanski, J | 1 |
| Rysz, J | 1 |
| Spychalska, M | 1 |
| Watala, C | 1 |
| Arnaout, A | 1 |
| De la Figuera von Wichmann, M | 1 |
| Llisterri Caro, JL | 1 |
| Tziomalos, K | 1 |
| Pagourelias, ED | 1 |
| Skaperdas, A | 1 |
| Hatzitolios, A | 1 |
| Karagiannis, A | 1 |
| Adams, RJ | 1 |
| Albers, G | 1 |
| Alberts, MJ | 2 |
| Benavente, O | 1 |
| Furie, K | 1 |
| Goldstein, LB | 1 |
| Gorelick, P | 1 |
| Halperin, J | 1 |
| Harbaugh, R | 1 |
| Johnston, SC | 1 |
| Katzan, I | 1 |
| Kelly-Hayes, M | 1 |
| Kenton, EJ | 1 |
| Marks, M | 1 |
| Sacco, RL | 1 |
| Antignani, PL | 1 |
| Bollinger, A | 1 |
| Biland, L | 1 |
| Brunner, U | 1 |
| Kappert, A | 1 |
| Krähenbühl, B | 1 |
| Mahler, F | 1 |
| Monti, M | 1 |
| Nachbur, B | 1 |
| Schneider, E | 1 |
| Widmer, LK | 1 |
| Bonchek, LI | 1 |
| Boerboom, LE | 1 |
| Olinger, GN | 1 |
| Pepper, JR | 1 |
| Munns, J | 1 |
| Hutchinson, L | 1 |
| Kissebah, AH | 1 |
| Paredero Del Bosque Martin, V | 1 |
| Hansson, L | 1 |
| Zanchetti, A | 1 |
| Rabbani, LE | 1 |
| Loscalzo, J | 1 |
| Lodder, J | 1 |
| Boiten, J | 1 |
| Forman, R | 1 |
| Aronow, WS | 1 |
| John, WG | 1 |
| Baglivo, E | 1 |
| Dosso, A | 1 |
| Pournaras, C | 1 |
| Geppert, A | 1 |
| Graf, S | 1 |
| Beckmann, R | 1 |
| Hornykewycz, S | 1 |
| Schuster, E | 1 |
| Binder, BR | 1 |
| Huber, K | 1 |
| Ariyo, A | 1 |
| Hennekens, CH | 1 |
| Ridker, PM | 1 |
| Dangas, G | 1 |
| Badimon, JJ | 1 |
| Smith, DA | 1 |
| Unger, AH | 1 |
| Levine, D | 1 |
| Shao, JH | 1 |
| Meraj, P | 1 |
| Fier, C | 1 |
| Fallon, JT | 1 |
| Ambrose, JA | 1 |
| Mahaffey, KW | 1 |
| Harrington, RA | 1 |
| Simoons, ML | 1 |
| Granger, CB | 1 |
| Graffagnino, C | 1 |
| Laskowitz, DT | 1 |
| Miller, JM | 1 |
| Sloan, MA | 1 |
| Berdan, LG | 1 |
| MacAulay, CM | 1 |
| Lincoff, AM | 1 |
| Deckers, J | 1 |
| Topol, EJ | 1 |
| Califf, RM | 1 |
| Carson, JJ | 1 |
| Yamada, M | 1 |
| Omata, K | 1 |
| Abe, F | 1 |
| Ito, S | 1 |
| Abe, K | 1 |
| Pershad, A | 1 |
| Kratzer, S | 1 |
| Cooper, A | 1 |
| Rolka, DB | 1 |
| Fagot-Campagna, A | 1 |
| Narayan, KM | 1 |
| Kim, HS | 1 |
| Waksman, R | 1 |
| Kollum, M | 1 |
| Bhargava, B | 1 |
| Kent, KM | 1 |
| Mintz, GS | 1 |
| Kolodgie, FD | 1 |
| Virmani, R | 1 |
| Foggensteiner, L | 1 |
| Mulroy, S | 1 |
| Firth, J | 1 |
| Gajdos, M | 1 |
| Mongiellová, V | 1 |
| Huttová, D | 1 |
| Cibulová, L | 1 |
| Krivosíková, Z | 1 |
| Spustová, V | 1 |
| Dzúrik, R | 1 |
| George, PB | 1 |
| Tobin, KJ | 1 |
| Corpus, RA | 1 |
| Devlin, WH | 1 |
| O'Neill, WW | 1 |
| Weisser, B | 1 |
| Düsing, R | 1 |
| Mengden, T | 1 |
| Abramson, B | 1 |
| Doughty, M | 1 |
| Mehta, R | 1 |
| Bruckman, D | 1 |
| Das, S | 1 |
| Karavite, D | 1 |
| Tsai, T | 1 |
| Eagle, K | 1 |
| Bredie, SJ | 1 |
| Wollersheim, HC | 1 |
| Verheugt, FW | 1 |
| Thien, T | 1 |
| Syvänne, M | 1 |
| Fisherman, EW | 1 |
| Rosset, D | 1 |
| Cohen, GN | 1 |
| Mustard, JF | 1 |
| Packham, MA | 2 |
| Kinlough-Rathbone, RL | 1 |
| Zannino, L | 1 |
| Salvadori, G | 1 |
| Strano, A | 1 |
| Novo, S | 1 |
| Stolarska, B | 1 |
| Skarzyńska, M | 1 |
| Prof Aiuto, G | 1 |
| Vaisrub, S | 1 |
| Rand, ML | 1 |
| Gross, PL | 1 |
| Barrow, DV | 1 |
| Whelan, AM | 1 |
| Price, SO | 1 |
| Fowler, SF | 1 |
| Hainer, BL | 1 |
| Bundlie, SR | 1 |
| Nozaki, S | 1 |
| Kihara, S | 1 |
| Kubo, M | 1 |
| Kameda, K | 1 |
| Matsuzawa, Y | 1 |
| Tarui, S | 1 |
| Lavie, CJ | 1 |
| Squires, RW | 1 |
| Gau, GT | 1 |
| Pedro, S | 1 |
| Renaud, S | 1 |
| Godu, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00006295] | 370 participants (Anticipated) | Observational | 2000-08-31 | Completed | |||
| Identifying and Overcoming Barriers to Diabetes Management in the Elderly: An Intervention Study[NCT01480804] | 48 participants (Actual) | Interventional | 2006-11-30 | Completed | |||
| Identifying and Overcoming Barriers to Diabetes Management in the Elderly: A Cost-effective Intervention Study[NCT01486290] | 52 participants (Actual) | Interventional | 2007-07-31 | Completed | |||
| Effects of Pulsatile IV Insulin Delivery on Diabetic Retinopathy[NCT00287651] | Phase 2/Phase 3 | 150 participants (Actual) | Interventional | 2005-11-30 | Terminated (stopped due to Administrative) | ||
| Clinical Feature and Outcome of Angiographic Coronary Artery Disease in Chronic Kidney Disease Patients[NCT00651521] | 1,000 participants (Actual) | Observational | 2009-04-30 | Active, not recruiting | |||
| [NCT00000500] | Phase 3 | 0 participants | Interventional | 1981-09-30 | Completed | ||
| Do Innovative Strategies Complement Medical Management to Reduce Cardiovascular Risk Factors Following Coronary Artery Bypass Graft Surgery?[NCT00462436] | Phase 2 | 35 participants (Anticipated) | Interventional | 2007-02-28 | Completed | ||
| Procedure and In-hospital Outcome of Patients Under 40 Years Old Undergoing Primary Percutaneous Coronary Intervention for Acute ST Elevated Myocardial Infarction in Assiut University[NCT03266328] | 117 participants (Anticipated) | Observational | 2017-09-01 | Not yet recruiting | |||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation in High Risk Primary Prevention (Patients With Metabolic Syndrome)[NCT00272311] | Phase 4 | 70 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| A Randomized, Double-Blind Trial to Test Higher- Versus Lower-Doses of Aspirin on Inflammatory Markers and Platelet Biomarkers and Nitric Oxide Formation & Endothelial Function in Secondary Prevention (Pts w/Chronic Stable Coronary Disease)[NCT00272337] | Phase 4 | 37 participants (Actual) | Interventional | 2006-10-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Changes in Heme oxygenase (HO-1) a downstream target of nitric oxide (NO) formation. (NCT00272311)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| Arm 1 of 5 Randomized Treatment Arms | 27.6 |
| Arm 2 of 5 Randomized Treatment Arms | 27.0 |
| Arm 3 of 5 Randomized Treatment Arms | 31.4 |
| Arm 4 of 5 Randomized Treatment Arms | 25.7 |
| Arm 5 of 5 Randomized Treatment Arms | 28.3 |
Heme oxygenase a downstream target of nitric oxide formation (NCT00272337)
Timeframe: Baseline to 3 Months (90-97 days)
| Intervention | ng/mL (Mean) |
|---|---|
| 1 of 5 Randomized Treatment Arms | 10.0 |
| 2 of 5 Randomized Treatment Arms | 11.2 |
| 3 of 5 Randomized Treatment Arms | 10.0 |
| 4 of 5 Randomized Treatment Arms | 11.0 |
| 5 of 5 Randomized Treatment Arms | 9.6 |
33 reviews available for aspirin and Hyperlipidemias
| Article | Year |
|---|---|
Effect of Statins on Platelet Activation and Function: From Molecular Pathways to Clinical Effects.
Topics: Aspirin; Blood Platelets; CD36 Antigens; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyp | 2021 |
[Atherothrombosis : Novel therapeutic strategies].
Topics: Animals; Anticoagulants; Aspirin; Carrier Proteins; Clinical Trials as Topic; Humans; Hydroxymethylg | 2018 |
Clinical pearls in general internal medicine.
Topics: Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Aspirin; Calcium; Cardiac Tamponade; Clavicle | 2018 |
Prevention of cardiovascular disease in women: highlights for the clinician of the 2011 American Heart Association Guidelines.
Topics: American Heart Association; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Cardiovascul | 2013 |
Factors influencing the decline in stroke mortality: a statement from the American Heart Association/American Stroke Association.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Air Pollution; American Heart Association; | 2014 |
[Cardiovascular event in elderly patients with diabetes mellitus].
Topics: Antihypertensive Agents; Aspirin; Atherosclerosis; Cardiovascular Diseases; Cause of Death; Clinical | 2013 |
[A change of attitude in lipidology, achievement of target levels. What comes next?].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremi | 2008 |
Pharmacological prevention and treatment of vascular dementia: approaches and perspectives.
Topics: Alzheimer Disease; Antihypertensive Agents; Aspirin; Cholinesterase Inhibitors; Cognition; Dementia, | 2012 |
Screening adults for type 2 diabetes: a review of the evidence for the U.S. Preventive Services Task Force.
Topics: Adult; Aspirin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diet; Evidence-Based Medicine; E | 2003 |
[Primary and secondary prevention of coronary artery disease].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Aspir | 2003 |
[Stroke prevention].
Topics: Administration, Oral; Aged; Anticoagulants; Antihypertensive Agents; Aspirin; Carotid Stenosis; Cont | 2003 |
Cardiovascular risk in patients with renal disease: treating the risk or treating the risk factor?
Topics: Adult; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Dietary Supplements; Folic Acid; H | 2004 |
Prevention of cardiovascular disease: an evidence-based clinical aid 2004.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiova | 2004 |
Prevention of cardiovascular events in diabetes.
Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Clopidogrel; Corona | 2003 |
[Primary prevention of cardiovascular disease].
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Aspirin; Body Mass Index; Cardiovascular Diseases | 2005 |
[Clinical guidelines for stroke].
Topics: Anticoagulants; Antipyrine; Arginine; Aspirin; Brain Edema; Edaravone; Fibrinolytic Agents; Free Rad | 2004 |
Prevention of cardiovascular events in diabetes.
Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Corona | 2004 |
Keeping the diabetic heart healthy.
Topics: Aspirin; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Family Practice; | 2005 |
Prevention of cardiovascular events in diabetes.
Topics: Angioplasty, Balloon; Antihypertensive Agents; Aspirin; Bezafibrate; Cardiovascular Diseases; Clopid | 2006 |
[Overview of cardiovascular risk factors].
Topics: Age Factors; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; As | 2006 |
Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?
Topics: Aspirin; Drug Combinations; Dyslipidemias; Health Services Needs and Demand; Humans; Hydroxymethylgl | 2007 |
Atherothrombotic insights into secondary prevention after acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agent | 1993 |
Incidence, natural history, and risk factors in lacunar infarction.
Topics: Age Factors; Aged; Aspirin; Cardiovascular Diseases; Cerebral Infarction; Diabetic Angiopathies; Fem | 1993 |
Management of postmyocardial infarction in the elderly patient.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Arrhyth | 1996 |
Glycated haemoglobin analysis.
Topics: Aspirin; Blood Glucose; Chemistry, Clinical; Chromatography, Affinity; Chromatography, High Pressure | 1997 |
Management of diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Diseases; Diabetic Nephropathies; | 2001 |
Risk factors and primary prevention of ischemic heart disease in women.
Topics: Alcohol Drinking; Antioxidants; Aspirin; Diabetes Complications; Exercise; Female; Humans; Hyperlipi | 2001 |
[Acetylsalicylic acid in primary prevention of cardiovascular events; literature study].
Topics: Aged; Aged, 80 and over; Arteriosclerosis; Aspirin; Diabetes Mellitus; Humans; Hyperlipidemias; Hype | 2002 |
[Treatment of coronary artery disease in a patient with adult-onset diabetes mellitus].
Topics: Adrenergic beta-Antagonists; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitor | 1999 |
Cardiovascular risk reduction in renal transplantation. Strategies for success.
Topics: Arteriosclerosis; Aspirin; Cardiovascular Agents; Cardiovascular Diseases; Comorbidity; Cost-Benefit | 2002 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
Platelets and thrombosis in the development of atherosclerosis and its complications.
Topics: Animals; Arteriosclerosis; Aspirin; Blood Platelets; Blood Vessels; Dipyridamole; Endothelium; Human | 1978 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type | 1979 |
[Prospects of antiaggregant therapy in prevention of atherosclerosis].
Topics: Animals; Anti-Inflammatory Agents; Anticoagulants; Arteriosclerosis; Aspirin; Blood Coagulation Diso | 1979 |
11 trials available for aspirin and Hyperlipidemias
| Article | Year |
|---|---|
A pragmatic randomized trial of a polypill-based strategy to improve use of indicated preventive treatments in people at high cardiovascular disease risk.
Topics: Administration, Oral; Adrenergic beta-1 Receptor Antagonists; Aged; Angiotensin-Converting Enzyme In | 2015 |
Clopidogrel provides significantly greater inhibition of platelet activity than aspirin when combined with atorvastatin after coronary artery bypass grafting: a prospective randomized study.
Topics: Adenosine Diphosphate; Aged; Aspirin; Atorvastatin; Clopidogrel; Comorbidity; Coronary Artery Bypass | 2010 |
Randomized controlled trial of symptomatic middle cerebral artery stenosis: endovascular versus medical therapy in a Chinese population.
Topics: Adult; Aged; Angioplasty; Asian People; Aspirin; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combi | 2012 |
Predictors of 14-year changes in the total cholesterol to high-density lipoprotein cholesterol ratio in men.
Topics: Adult; Aged; Aged, 80 and over; Alcohol Drinking; Aspirin; beta Carotene; Body Weight; Cholesterol; | 2004 |
Effect of statins and aspirin alone and in combination on clinical outcome in dyslipidaemic patients with coronary heart disease. A subgroup analysis of the GREACE study.
Topics: Adult; Aged; Anticholesteremic Agents; Aspirin; Case-Control Studies; Coronary Disease; Drug Synergi | 2005 |
The Hypertension Optimal Treatment (HOT) Study--patient characteristics: randomization, risk profiles, and early blood pressure results.
Topics: Adrenergic beta-Antagonists; Age Distribution; Aged; Aged, 80 and over; Angiotensin-Converting Enzym | 1994 |
Lipoprotein (a), lipids, aspirin, and risk of myocardial infarction in the Physician's Health Study.
Topics: Aspirin; Case-Control Studies; Cohort Studies; Double-Blind Method; Humans; Hyperlipidemias; Lipopro | 1998 |
Pravastatin therapy in hyperlipidemia: effects on thrombus formation and the systemic hemostatic profile.
Topics: Aged; Aspirin; Blood Coagulation Factors; Cholesterol, LDL; Coronary Thrombosis; Double-Blind Method | 1999 |
Stroke in patients with acute coronary syndromes: incidence and outcomes in the platelet glycoprotein IIb/IIIa in unstable angina. Receptor suppression using integrilin therapy (PURSUIT) trial. The PURSUIT Investigators.
Topics: Acute Disease; Age Factors; Aged; Angina, Unstable; Aspirin; Brain Damage, Chronic; Cerebral Hemorrh | 1999 |
Ciprofibrate increases plasma concentration of platelet-derived growth factor AB in patients with advanced atherosclerosis and hyperlipidemia independently of its hypolipidemic effects.
Topics: Aged; Arteriosclerosis; Aspirin; Clofibric Acid; Drug Therapy, Combination; Female; Fibric Acids; Fi | 2001 |
The effect of aspirin on niacin-induced cutaneous reactions.
Topics: Adult; Aspirin; Double-Blind Method; Drug Therapy, Combination; Female; Flushing; Humans; Hyperlipid | 1992 |
72 other studies available for aspirin and Hyperlipidemias
| Article | Year |
|---|---|
A Decision-Support Software to Improve the Standard Care in Chinese Type 2 Diabetes.
Topics: Antihypertensive Agents; Aspirin; Blood Glucose; Blood Pressure; Cardiovascular Diseases; China; Dec | 2019 |
[2019 ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases: what's new? The diabetologist's point of view].
Topics: Anticoagulants; Aspirin; Cardiology; Cholesterol, LDL; Diabetic Cardiomyopathies; Europe; Heart Dise | 2020 |
Clopidogrel Prophylaxis Abates Myocardial Ischemic Injury and Inhibits the Hyperlipidemia-Inflammation Loop in Hypercholestrolemic Mice.
Topics: Animals; Aspirin; Clopidogrel; Disease Models, Animal; Humans; Hypercholesterolemia; Hyperlipidemias | 2020 |
Baseline clinical characteristics and patient profile of the TURKMI registry: Results of a nation-wide acute myocardial infarction registry in Turkey.
Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Angiotensin Receptor Antagonists; Angiotensin-Conver | 2020 |
Long-term continuous use of proton-pump inhibitors is associated with renal function decline in patients without acute kidney injury.
Topics: Acute Kidney Injury; Aged; Angiotensin Receptor Antagonists; Anti-Inflammatory Agents, Non-Steroidal | 2021 |
Reducing CV risk in diabetes: An ADA update.
Topics: Antihypertensive Agents; Aspirin; Benzhydryl Compounds; Cardiovascular Diseases; Contraindications; | 2017 |
UPLC-Q-TOF/MS-based urine and plasma metabonomics study on the ameliorative effects of aspirin eugenol ester in hyperlipidemia rats.
Topics: Administration, Oral; Animals; Aspirin; Biomarkers; Cholesterol, HDL; Cholesterol, LDL; Diet, High-F | 2017 |
Feces and liver tissue metabonomics studies on the regulatory effect of aspirin eugenol eater in hyperlipidemic rats.
Topics: Administration, Oral; Amino Acids; Animals; Aspirin; Bile Acids and Salts; Body Weight; Cholesterol, | 2017 |
Monotherapy of acetylsalicylic acid or warfarin for prevention of ischemic stroke in low-risk atrial fibrillation: A Easter Asian population-based study.
Topics: Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Comparative Effectiveness | 2019 |
Aspirin eugenol ester regulates cecal contents metabolomic profile and microbiota in an animal model of hyperlipidemia.
Topics: Animals; Aspirin; Cecum; Diet; Disease Models, Animal; Eugenol; Gastrointestinal Microbiome; Hyperli | 2018 |
Fixed Dose Combination Formulations: Multilayered Platforms Designed for the Management of Cardiovascular Disease.
Topics: Aspirin; Cardiovascular Diseases; Dosage Forms; Drug Combinations; Drug Compounding; Drug Delivery S | 2019 |
Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.
Topics: Adult; Aspirin; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Complicat | 2013 |
Risk Factors and Treatment Strategies in Patients With Retinal Vascular Occlusions.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Female; Humans; Hyperlipidemias; Hypertension; Male; Middle | 2015 |
Patients with risk factors have higher plasma levels of lysophosphatidic acid: a promising surrogate marker for blood platelet activation.
Topics: Aspirin; Biomarkers; Blood Platelets; Cross-Sectional Studies; Female; Humans; Hyperlipidemias; Hype | 2014 |
Low-dose aspirin ameliorated hyperlipidemia, adhesion molecule, and chemokine production induced by high-fat diet in Sprague-Dawley rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aorta, Thoracic; Aspirin; Atherosclerosis; Blood P | 2014 |
Implementation of best medical therapy for cardiovascular risk factors in vascular surgery patients treated in a tertiary referral regional unit.
Topics: Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Female; Guideline Adherence; Humans; Hydr | 2014 |
Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking.
Topics: Aged; Aspirin; Cholesterol; Diabetes Mellitus, Type 2; Drug Resistance; Female; Hematocrit; Humans; | 2014 |
Analysis of periinterventional complications of intracranial angioplasty and stenting: a single center experience.
Topics: Aged; Angioplasty; Aspirin; Blood Vessel Prosthesis Implantation; Clopidogrel; Diabetes Complication | 2014 |
Clopidogrel response variability is associated with endothelial dysfunction in coronary artery disease patients receiving dual antiplatelet therapy.
Topics: Activation, Metabolic; Aged; Aspirin; Brachial Artery; Clopidogrel; Coronary Disease; Cytochrome P-4 | 2015 |
The effect of statins on the occurrence of peptic ulcer.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Da | 2015 |
Regulation effect of Aspirin Eugenol Ester on blood lipids in Wistar rats with hyperlipidemia.
Topics: Animals; Aspirin; Dietary Fats; Eugenol; Hyperlipidemias; Hypolipidemic Agents; Male; Random Allocat | 2015 |
Lowering effects of aspirin eugenol ester on blood lipids in rats with high fat diet.
Topics: Animals; Aspirin; Cholesterol; Diet, High-Fat; Eugenol; Hyperlipidemias; Hypolipidemic Agents; Male; | 2016 |
Rhabdomyolysis resulting from pharmacologic interaction between erlotinib and simvastatin.
Topics: Aged; Amlodipine; Anti-Inflammatory Agents, Non-Steroidal; Anticholesteremic Agents; Antihypertensiv | 2008 |
["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Diabetes | 2009 |
Desensitization to clopidogrel: a growing need.
Topics: Aspirin; Cardiac Catheterization; Clopidogrel; Desensitization, Immunologic; Drug Therapy, Combinati | 2010 |
Neutrophilia predicts death and heart failure after myocardial infarction: a community-based study.
Topics: Adrenergic beta-Antagonists; Aged; Aspirin; Body Mass Index; Cell Count; Cohort Studies; Coronary Ar | 2009 |
"War and Peace" with Barrett's esophagus.
Topics: Adenocarcinoma; Aged; Anti-Ulcer Agents; Antihypertensive Agents; Aspirin; Barrett Esophagus; Celeco | 2011 |
A population pharmacokinetic-pharmacodynamic model for simvastatin that predicts low-density lipoprotein-cholesterol reduction in patients with primary hyperlipidaemia.
Topics: Adult; Aspirin; Cholesterol, LDL; Computer Simulation; Dose-Response Relationship, Drug; Drug Intera | 2011 |
High antiphospholipid antibody levels are associated with statin use and may reflect chronic endothelial damage in non-autoimmune thrombosis: cross-sectional study.
Topics: Aged; Antibodies, Antiphospholipid; Aspirin; Biomarkers; Chronic Disease; Cross-Sectional Studies; E | 2012 |
Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients.
Topics: Acetylcholine; Age Factors; Aspirin; Coronary Angiography; Coronary Vasospasm; Diabetes Complication | 2012 |
Utilization of statins and aspirin among patients with diabetes and hyperlipidemia: Taiwan, 1998-2006.
Topics: Adult; Aged; Aspirin; Coronary Disease; Diabetes Mellitus; Drug Utilization; Female; Humans; Hydroxy | 2012 |
Doctor, my dentist wants your opinion.
Topics: Angioplasty; Antibiotic Prophylaxis; Aspirin; Dental Care for Chronically Ill; Dentists; Drug Intera | 2013 |
Research pointers: Platelet responsiveness to aspirin in patients with hyperlipidaemia.
Topics: Aspirin; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Drug Resistance; Female; Humans; Hype | 2003 |
Heart attack and stroke prevention guidelines emphasize lifestyle factors.
Topics: Adult; Age Factors; American Heart Association; Aspirin; Diabetes Mellitus, Type 2; Diet; Exercise; | 2002 |
Differential effect of aspirin on platelet aggregation in patients with coronary artery disease in relation with associated risk factors.
Topics: Adult; Aged; Aspirin; Coronary Disease; Diabetic Angiopathies; Double-Blind Method; Humans; Hyperlip | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Guidelines for improving the care of the older person with diabetes mellitus.
Topics: Accidental Falls; Aged; Aspirin; Cognition Disorders; Depression; Diabetes Complications; Diabetes M | 2003 |
Niacin and the National Cholesterol Education Program Adult Treatment Panel III Guidelines: case studies.
Topics: Aspirin; Atenolol; Blood Chemical Analysis; Coronary Disease; Female; Humans; Hyperlipidemias; Hyper | 2003 |
[Diagnosis and therapy of stable angina in Russian Federation (International Study ATP - angina treatment pattern)].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Angiotens | 2003 |
[Primary prevention of stroke. What helps--what does not help? The guidelines of the German Society of Neurology briefly summarized].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aged; Alcohol Drinking; Anticholesteremic | 2003 |
Preventing diabetic retinopathy through control of systemic factors.
Topics: Anticoagulants; Aspirin; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Female; G | 2003 |
A case of frequently recurring amaurosis fugax with atherothrombotic ophthalmic artery occlusion.
Topics: Amaurosis Fugax; Angiography, Digital Subtraction; Arterial Occlusive Diseases; Arteriosclerosis; As | 2004 |
Consensus statement for the prevention of vascular disease.
Topics: Aged; Aspirin; Atrial Fibrillation; Australia; Diabetes Complications; Diabetes Mellitus; Family Pra | 2004 |
Variability among cardiologists in the management of patients under secondary prevention of ischemic heart disease.
Topics: Ambulatory Care Facilities; Aspirin; Cardiology; Cholesterol, LDL; Cross-Sectional Studies; Epidemio | 2004 |
[Secondary prevention of stroke].
Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Diabetes Complications; Guideline Adherence; Humans; H | 2004 |
Outcomes of acute coronary syndrome in a large Canadian cohort: impact of chronic renal insufficiency, cardiac interventions, and anemia.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Anemia; Angina, Unstable; Angiotensin-Converting Enzyme In | 2005 |
Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
Topics: Aspirin; Atorvastatin; Carotid Stenosis; Coronary Artery Disease; Drug Therapy, Combination; Heptano | 2006 |
Reduced blood platelet sensitivity to aspirin in coronary artery disease: are dyslipidaemia and inflammatory states possible factors predisposing to sub-optimal platelet response to aspirin?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; C-Reactive Protein; Cholesterol; | 2006 |
Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack.
Topics: Aspirin; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Combinations; Dru | 2008 |
[Medical therapy of peripheral arteriopathies].
Topics: Arterial Occlusive Diseases; Aspirin; Blood Coagulation; Blood Viscosity; Erythrocytes; Humans; Hype | 1984 |
[Therapy of peripheral arterial occlusive diseases. Round table conference].
Topics: Alprostadil; Angioplasty, Balloon; Anti-Bacterial Agents; Anticoagulants; Arterial Occlusive Disease | 1983 |
Prevention of lipid accumulation in experimental vein bypass grafts by antiplatelet therapy.
Topics: Animals; Arteriosclerosis; Aspirin; Coronary Artery Bypass; Dipyridamole; Hyperlipidemias; Lipid Met | 1982 |
[Indications for surgical treatment and medical treatment of atherosclerosis].
Topics: Arteriosclerosis; Aspirin; Cholestyramine Resin; Clofibrate; Dextrothyroxine; Dipyridamole; Humans; | 1980 |
Thrombus and branch retinal vein occlusion.
Topics: Aspirin; Calcium Channel Blockers; Fluorescein Angiography; Fundus Oculi; Humans; Hyperlipidemias; H | 1997 |
Concentration of endogenous tPA antigen in coronary artery disease: relation to thrombotic events, aspirin treatment, hyperlipidemia, and multivessel disease.
Topics: Adult; Aged; Arteriosclerosis; Aspirin; Coronary Disease; Cross-Sectional Studies; Female; Humans; H | 1998 |
Pharmacist-coordinated program to improve use of pharmacotherapies for reducing risk of coronary artery disease in low-income adults.
Topics: Adult; Aged; Anticholesteremic Agents; Aspirin; Coronary Disease; Female; Humans; Hyperlipidemias; M | 1999 |
Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia.
Topics: Aspirin; Dinoprost; Dipyridamole; Eicosapentaenoic Acid; Epoprostenol; Humans; Hyperlipidemias; Hype | 1999 |
Coronary revascularization and aggressive lipid lowering.
Topics: Aspirin; Atorvastatin; Coronary Stenosis; Heptanoic Acids; Humans; Hyperlipidemias; Hypertension; Hy | 1999 |
Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey.
Topics: Adult; Albuminuria; Angina Pectoris; Aspirin; Cardiovascular Diseases; Diabetes Complications; Diabe | 2001 |
Edge stenosis after intracoronary radiotherapy: angiographic, intravascular, and histological findings.
Topics: Aged; Angioplasty, Balloon, Laser-Assisted; Anticoagulants; Aspirin; Brachytherapy; Clopidogrel; Com | 2001 |
Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Pressure | 2001 |
[Arterial hypertension - the specific case].
Topics: Aspirin; Carotid Artery, Internal; Carotid Stenosis; Diabetes Complications; Diet; Exercise; Follow- | 2001 |
Acute myocardial infarction in the young--The University of Michigan experience.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anticoagulants; Aspirin; Coronary Artery B | 2002 |
Serum triglyceride and cholesterol levels and lipid electrophoretic patterns in intrinsic and extrinsic allergic states.
Topics: Adult; Aspirin; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Cholesterol; Diabetes Complicati | 1977 |
[In vivo platelet aggregation in coronary disease and following administration of various drugs].
Topics: Aspirin; Coronary Disease; Humans; Hyperlipidemias; Platelet Aggregation | 1977 |
[Problems of arteriosclerosis epidemiology. Analysis of risk factors with a view to a possible therapy].
Topics: Anti-Inflammatory Agents; Anticoagulants; Antihypertensive Agents; Arteriosclerosis; Aspirin; Blood | 1976 |
Editorial: Platelet aggregation.
Topics: Adenosine Diphosphate; Aspirin; Cerebrovascular Disorders; Coronary Disease; Glucose; Humans; Hyperl | 1975 |
Acute in vitro effects of ethanol on responses of platelets from cholesterol-fed and Watanabe heritable hyperlipidemic rabbits.
Topics: Adenosine Diphosphate; Animals; Aspirin; Blood Platelets; Cholesterol, Dietary; Collagen; Ethanol; H | 1992 |
Ischemic stroke. How to keep the first one from happening.
Topics: Aspirin; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hyperlipidemias; Hypertension; I | 1991 |
Increased compliance of niceritrol treatment by addition of aspirin: relationship between changes in prostaglandins and skin flushing.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Aspirin; Cholesterol; Dinoprostone; Flushing; Humans; Hyp | 1987 |
Prevention of cardiovascular disease. Of what value are risk factor modification, exercise, fish consumption, and aspirin therapy?
Topics: Animals; Aspirin; Cardiovascular Diseases; Feeding Behavior; Fish Products; Humans; Hyperlipidemias; | 1987 |
Letter: Drug-induced acanthosis nigricans.
Topics: Acanthosis Nigricans; Adult; Aspirin; Humans; Hyperlipidemias; Lipoproteins; Nicotinic Acids; Time F | 1974 |
Thrombosis prevention by acetylsalicylic acid in hyperlipemic rats.
Topics: Adenine Nucleotides; Adult; Animals; Aspirin; Blood Coagulation Tests; Collagen; Disease Models, Ani | 1970 |